Lv4
470 积分 2024-12-10 加入
International Consensus on Use of Continuous Glucose Monitoring
9小时前
待确认
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
1个月前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
5个月前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
5个月前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
7个月前
已完结
Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials
7个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
8个月前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
8个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
9个月前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
9个月前
已完结
皖公网安备34019202002308
